Early Versus Late Laparoscopic Exploration of Common Bile Duct After Failure of Extraction of Common Bile Duct Stones by ERCP

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05823181
Collaborator
(none)
50
26

Study Details

Study Description

Brief Summary

The goal of this work is to assess the best time to perform LC combined with LCBD exploration and the feasibility and safety of such procedure in patients with combined GBS and CBDS after failure of ERCP extraction of CBD stones .

Condition or Disease Intervention/Treatment Phase
  • Device: laparoscopy

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Early Versus Late Laparoscopic Exploration of Common Bile Duct After Failure of Extraction of Common Bile Duct Stones by ERCP
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Nov 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Early laparoscopic exploration of common bile duct

Early laparoscopic exploration of common bile duct after failure of extraction of common bile duct stones by ERCP

Device: laparoscopy
laparoscopic exploration of common bile duct

Late laparoscopic exploration of common bile duct

late laparoscopic exploration of common bile duct after failure of extraction of common bile duct stones by ERCP

Device: laparoscopy
laparoscopic exploration of common bile duct

Outcome Measures

Primary Outcome Measures

  1. intraoperative complications [Baseline]

    Assess the operative time in hours intraoperative blood loss in millilitres intraoperative organ injury (yes or no) conversion to open surgery (yes or no)

Secondary Outcome Measures

  1. postoperative complications [Baseline]

    Postoperative bleeding in millilitres biliary leakage in millilitres missed stone (yes or no) recumbency complications which are monitored for 30 days postoperatively. 5.Overall length of hospital stay and if Intensive Care Unit (ICU) stay needed will also be recorded in days.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. All patients that presented with calcular obstructive jaundice 2ry to CBD stones.

  2. Failed of extraction of common bile duct stone by ERCP.

Exclusion Criteria:
  1. patients presented by cholangitis.

  2. patients presented by acute pancreatitis.

  3. Patients that developed post ERCP pancreatitis ,bleeding , perforation.

  4. history of previous biliary surgery rather than cholecystectomy.

  5. history of major upper abdominal surgery.

  6. pregnant females.

  7. patients with liverchirosis, abdominal malignancy , and those unfit for surgery.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ebram Abdelmalak Abd, Principal Investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT05823181
Other Study ID Numbers:
  • CBD stone
First Posted:
Apr 21, 2023
Last Update Posted:
Apr 21, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2023